T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
36 hedge funds and large institutions have $90.4M invested in T2 Biosystems, Inc in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 9 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
51% more capital invested
Capital invested by funds: $59.8M → $90.4M (+$30.6M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
33% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 9
6% more funds holding
Funds holding: 34 → 36 (+2)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $51K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$4.51M |
| 2 |
Morgan Stanley
New York
|
+$3.71M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.88M |
| 4 |
SM
Senvest Management
New York
|
+$1.86M |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aisling Capital
New York
|
-$4.89M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$260K |
| 3 |
ECM
Element Capital Management
New York
|
-$230K |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$180K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$177K |
TTOO Hedge Fund Activity: Q3 2017 in Review
36 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2017, worth a combined $90.4M — up 51% from $59.8M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new TTOO positions and 9 closed out — a net gain of 3 holders — while 9 added to existing stakes and 2 trimmed.
The largest buyer was Lagoda Investment Management, adding an estimated $4.51M. The largest seller was Aisling Capital, exiting entirely with an estimated $4.89M sold.
- 36 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2017, up from 34 in Q2 2017.
- Funds reported $90.4M of T2 Biosystems, Inc stock for Q3 2017, up 51% quarter-over-quarter.
- 12 funds opened new T2 Biosystems, Inc positions in Q3 2017 and 9 closed out, a net change of +3 holders.
- The largest T2 Biosystems, Inc buyer in Q3 2017 was Lagoda Investment Management, an estimated $4.51M added.
- The largest T2 Biosystems, Inc seller in Q3 2017 was Aisling Capital, an estimated $4.89M sold.
Based on aggregated 13F filings for Q3 2017.